CST-103

· CuraSen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CST-103, covering 2024-07-03 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) [Phase 2]

See pricing